APA (7th ed.) Citation

Matteelli, A., Russo, G., Rossi, L., Cerini, C., Cimaglia, C., Formenti, B., . . . Girardi, E. (2025). Four months daily rifampicin vs. 3 months daily rifampicin/isoniazid for the treatment of tuberculosis infection in asylum seekers: A randomized controlled trial. Clinical microbiology and infection, 31(8), 1330-1335. https://doi.org/10.1016/j.cmi.2025.02.037

Chicago Style (17th ed.) Citation

Matteelli, Alberto, et al. "Four Months Daily Rifampicin Vs. 3 Months Daily Rifampicin/isoniazid for the Treatment of Tuberculosis Infection in Asylum Seekers: A Randomized Controlled Trial." Clinical Microbiology and Infection 31, no. 8 (2025): 1330-1335. https://doi.org/10.1016/j.cmi.2025.02.037.

MLA (9th ed.) Citation

Matteelli, Alberto, et al. "Four Months Daily Rifampicin Vs. 3 Months Daily Rifampicin/isoniazid for the Treatment of Tuberculosis Infection in Asylum Seekers: A Randomized Controlled Trial." Clinical Microbiology and Infection, vol. 31, no. 8, 2025, pp. 1330-1335, https://doi.org/10.1016/j.cmi.2025.02.037.